Envestnet Asset Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $93.2K | Buy |
10,401
+119
| +1% | +$1.07K | ﹤0.01% | 4344 |
|
|
2025
Q1 | $77.1K | Buy |
+10,282
| New | +$77.1K | ﹤0.01% | 4265 |
|
|
2024
Q3 | – | Sell |
-10,335
| Closed | -$63.9K | – | 4228 |
|
|
2024
Q2 | $63.9K | Sell |
10,335
-7,460
| -42% | -$46.1K | ﹤0.01% | 4090 |
|
|
2024
Q1 | $90.4K | Buy |
+17,795
| New | +$90.4K | ﹤0.01% | 4071 |
|
|
2018
Q3 | – | Sell |
-119
| Closed | -$1K | – | 1369 |
|
|
2018
Q2 | $1K | Hold |
119
| – | – | ﹤0.01% | 2786 |
|
|
2018
Q1 | $1K | Hold |
119
| – | – | ﹤0.01% | 2759 |
|
|
2017
Q4 | $1K | Hold |
119
| – | – | ﹤0.01% | 2895 |
|
|
2017
Q3 | $1K | Hold |
119
| – | – | ﹤0.01% | 2841 |
|
|
2017
Q2 | $1K | Hold |
119
| – | – | ﹤0.01% | 2982 |
|
|
2017
Q1 | $1K | Hold |
119
| – | – | ﹤0.01% | 3042 |
|
|
2016
Q4 | $1K | Buy |
+119
| New | +$1K | ﹤0.01% | 3020 |
|